Remdesivir does not reduce mortality in ventilated patients with COVID-19
Physician's Weekly,
1. No significant decrease in mortality risk was seen in ventilated patients with COVID-19 on remdesivir compared to control. 2.
JJ 20 Outpatient Medications for COVID-19
Emergency Medicine Cases,
In this Journal Jam podcast we dig deep into the science of FDA-approved outpatient medications for COVID with 3 critical…
JJ 20 Outpatient Medications for COVID-19
Emergency Medicine Cases,
In this Journal Jam podcast we dig deep into the science of FDA-approved outpatient medications for COVID with 3 critical…
Remdesivir: the evidence
First10EM,
This is part of the ongoing series of articles updating the evidence on current COVID-19 therapies. The rest of the series can…
The Unspoken Victims of COVID-19
Counter Punch,
So, one set of studies suggested that Omicron is a less severe disease than Delta, but because the research was only conducted…
Ask about these treatments if you get COVID
Whats New,
Even with three highly effective vaccines widely available throughout the country, the delta version of SARS-CoV-2 continues to…
First real-life trial of monoclonal antibodies for COVID-19
Sciworthy,
For all of the damage the coronavirus pandemic has caused, it has undoubtedly pushed medical innovation forward. Ivermectin…
The Truth About Ivermectin
io9: Top,
Ivermectin, a long-used antiparasitic treatment for both humans and animals, has recently usurped hydroxychloroquine as the “do…
WHO begins global trial testing trio of drugs to treat severe COVID-19
Gizmag Emerging Technology Magazine,
The World Health Organization is launching a large-scale global clinical trial testing whether a trio of pre-existing drugs can…
Covid-19: Ya hay vacunas y funcionan pero ¿qué pasa con los medicamentos?
EcoAvant.com - Portada,
Día a día, observamos que las vacunas contra la COVID-19 tienen el potencial de disminuir drásticamente la gravedad de la…
Why are antiviral drugs for COVID-19 difficult to find?
Advanced Science News,
Viruses are so varied and evolve so quickly that creating effective treatments against them becomes a daunting task. The post…
Изобретая колесо
N+1: научные статьи, новости, открытия,
Что происходит с разработкой лекарств от ковида
The clinical trials fighting COVID-19: platform and repurposed drug trials
On Medicine,
In our blog for Clinical Trials Day 2020 we summarized the COVID-19 studies that had been registered so far at the ISRCTN…
Le remdesivir chez les patients atteints de la COVID-19 [Pratique]
Canadian Medical Association Journal current issue,
Manual de Desfechos: O Elo Perdido das Evidências
Medicina Baseada Evidências,
Este texto foi escrito a partir do conteúdo que gravei para o episódio do MBE Podcast dedicado a “Desfechos”. A densidade…
Covid-19: Peer-Reviewed Findings Show Quicker Recovery with Remdesivir
Physician's Weekly,
Hospitalized patients had shorter time to clinical…
TWiV 724: COVID-19 clinical update #51 with Dr. Daniel Griffin
This Week in Virology with Vincent Racaniello,
In COVID-19 clinical update #51, Daniel Griffin reviews use of two masks, effectiveness of testing in nursing homes, updates on…
Remdesivir for patients with COVID-19 [Practice]
Canadian Medical Association Journal current issue,
COVID-19 hospitalization requirements in low-resource settings: mathematical modeling can help!
Nature Microbiology Community,
Using mathematical modelling, we combine theoretical assumptions with real-world data to the study of the ongoing epidemic in a…
5th January 2021 - the COVID-19 coronavirus compendium
Nature Microbiology Community,
Vaccines, anti-virals, and re-infection
Renalism Returns with Remdesivir
Blog - NephJC,
#NephJC Chat Tuesday December 29 at 9 pm EasternWednesday December 30, 2020 at 9 pm Indian Standard Time Wednesday December 30…
The Emerging Evidence for a Genetic Susceptibility to Severe Covid-19. St Emlyn’s
St.Emlyn's Blog,
St.Emlyn's - Emergency Medicine #FOAMed A defining feature of the COVID-19 pandemic has been the wide spectrum of clinical…
Ann Robinson’s research reviews—12 December 2020
Latest BMJ blogs,
Ann Robinson reviews the latest research from the top medical…
Primecuts – This Week in The Journals - Clinical Correlations
Clinical Correlations,
By Victoria Gore…
TWiV 692: COVID-19 clinical update #40 with Dr. Daniel Griffin
This Week in Virology with Vincent Racaniello,
Daniel Griffin provides his weekly clinical report on COVID-19, including the anticipated EUA for the Pfizer mRNA vaccine…
Antiviral Drugs Have No Effect on Mortality in COVID-19
Physician's Weekly,
FRIDAY, Dec. 4, 2020 (HealthDay News) — For hospitalized patients with COVID-19, remdesivir, hydroxychloroquine, lopinavir, and…
Учёные назвали лекарства, которые не помогают при коронавирусе
«Life.ru» — информационный портал,
Они исследовали средства, на которые ранее обращала внимание ВОЗ. Читать далее...
Analysis finds four repurposed antiviral drugs have little or no effect on patients hospitalised for COVID-19
University of Bristol news,
Repurposed antiviral drugs - remdesivir, hydroxychloroquine, lopinavir and interferon - to treat COVID-19 appear to have little…
WHO Trial Finds No Covid-19 Mortality Benefit for Antiviral Drugs
Physician's Weekly,
Antivirals, including remdesiver, failed to reduce ventilation, or length-of-stay Covid-19 treatment regimens including…